HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Kobayashi Selected Research

salivary peptide P-C

8/2001Reduction of incretin-like salivatin in saliva from patients with type 2 diabetes and in parotid glands of streptozotocin-diabetic BALB/c mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Kobayashi Research Topics

Disease

54Neoplasms (Cancer)
01/2019 - 01/2000
19Infections
10/2016 - 01/2000
15Necrosis
01/2016 - 06/2000
11Type 2 Diabetes Mellitus (MODY)
10/2017 - 02/2000
11Stomach Neoplasms (Stomach Cancer)
06/2015 - 10/2000
10Inflammation (Inflammations)
01/2019 - 04/2000
10Carcinoma (Carcinomatosis)
08/2007 - 02/2000
10Chronic Hepatitis C
05/2004 - 01/2000
9Prostatic Neoplasms (Prostate Cancer)
06/2017 - 01/2000
9Neoplasm Metastasis (Metastasis)
11/2014 - 01/2000
8Body Weight (Weight, Body)
01/2012 - 10/2000
8Hepatitis
01/2004 - 09/2000
7Insulin Resistance
12/2014 - 02/2000
7Hepatocellular Carcinoma (Hepatoma)
01/2012 - 01/2000
6Rheumatoid Arthritis
01/2018 - 01/2000
6Hemorrhage
06/2017 - 08/2000
6Asthma (Bronchial Asthma)
08/2015 - 04/2001
6Carcinogenesis
06/2009 - 02/2000
5Pain (Aches)
01/2018 - 09/2001
5Ulcer
01/2014 - 04/2000
5Leukemia
12/2012 - 01/2000
5Fibrosis (Cirrhosis)
06/2009 - 08/2000
5Lung Neoplasms (Lung Cancer)
01/2009 - 12/2000
5Ischemia
06/2008 - 05/2000
5Breast Neoplasms (Breast Cancer)
11/2005 - 10/2000
5Atherosclerosis
11/2001 - 02/2000
4Osteonecrosis (Kienbock's Disease)
01/2019 - 01/2000
4Chronic Hepatitis B
11/2014 - 02/2001
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2012 - 09/2000
4Malignant Hyperthermia
03/2012 - 12/2007
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2011 - 12/2000
4Cardiovascular Diseases (Cardiovascular Disease)
10/2011 - 02/2000
4Liver Diseases (Liver Disease)
09/2009 - 08/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2006 - 12/2000
4Hepatitis C
05/2004 - 01/2000
4Adenoma (Adenomas)
11/2002 - 01/2000
4Burns
11/2001 - 03/2001
3Neutropenia
01/2021 - 05/2001
3Wounds and Injuries (Trauma)
01/2019 - 04/2001
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 09/2000
3Vasculitis (Vasculitides)
10/2016 - 06/2001
3Carotid Stenosis (Carotid Artery Stenosis)
06/2016 - 05/2013
3Pathologic Constriction (Stenosis)
06/2016 - 01/2000
3Renal Cell Carcinoma (Grawitz Tumor)
01/2012 - 04/2000
3Interstitial Lung Diseases (Interstitial Lung Disease)
12/2011 - 01/2001
3Diabetic Nephropathies (Diabetic Nephropathy)
11/2011 - 07/2005
3Hyperthyroidism
03/2011 - 11/2000
3Hypoxia (Hypoxemia)
07/2009 - 09/2001

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
06/2017 - 01/2000
17CytokinesIBA
02/2010 - 05/2000
13InterferonsIBA
03/2011 - 01/2000
12Insulin (Novolin)FDA Link
12/2014 - 01/2000
11DNA (Deoxyribonucleic Acid)IBA
08/2016 - 01/2000
11LipidsIBA
04/2014 - 02/2000
8Pharmaceutical PreparationsIBA
01/2017 - 04/2000
8Messenger RNA (mRNA)IBA
07/2008 - 06/2000
8EnzymesIBA
05/2007 - 01/2000
7Glucose (Dextrose)FDA LinkGeneric
09/2015 - 08/2001
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2012 - 08/2000
7InterleukinsIBA
05/2007 - 08/2000
7CholesterolIBA
10/2005 - 02/2000
6CalciumIBA
03/2015 - 02/2000
6SteroidsIBA
07/2012 - 01/2001
6AntigensIBA
03/2011 - 01/2000
6Interleukin-8 (Interleukin 8)IBA
12/2005 - 08/2000
5RNA (Ribonucleic Acid)IBA
08/2016 - 01/2000
5Indicators and Reagents (Reagents)IBA
11/2005 - 06/2001
5Triglycerides (Triacylglycerol)IBA
10/2005 - 02/2000
5Anti-Bacterial Agents (Antibiotics)IBA
11/2001 - 01/2001
5p38 Mitogen-Activated Protein KinasesIBA
07/2001 - 01/2000
5Interleukin-10 (Interleukin 10)IBA
01/2001 - 08/2000
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2016 - 06/2001
4Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2014 - 01/2000
4CreatinineIBA
11/2011 - 09/2001
4AutoantibodiesIBA
03/2011 - 10/2000
4Cisplatin (Platino)FDA LinkGeneric
07/2009 - 10/2000
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2009 - 01/2000
4ImmunosorbentsIBA
05/2007 - 06/2001
4Interleukin-4 (Interleukin 4)IBA
11/2003 - 07/2000
4AcidsIBA
01/2003 - 01/2000
4Immunoglobulin G (IgG)IBA
08/2002 - 10/2000
4soblidotin (TZT 1027)IBA
07/2001 - 08/2000
3Adenosine Triphosphatases (ATPase)IBA
01/2017 - 04/2000
3Protons (Proton)IBA
05/2013 - 08/2000
3Carcinoembryonic AntigenIBA
11/2012 - 08/2004
3Dihydrotachysterol (AT 10)IBA
11/2011 - 10/2000
3Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
03/2011 - 12/2007
3Monoclonal AntibodiesIBA
03/2011 - 05/2002
3beta CateninIBA
07/2010 - 05/2000
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2009 - 09/2001

Therapy/Procedure

47Therapeutics
01/2018 - 01/2000
16Drug Therapy (Chemotherapy)
01/2016 - 01/2000
7Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2006 - 03/2000
5Radiotherapy
12/2006 - 06/2000
4Ligation
08/2013 - 01/2000
4Aftercare (After-Treatment)
01/2012 - 01/2000
3Transplantation
01/2017 - 04/2001
3Surgical Instruments (Clip)
01/2014 - 08/2008
3Stents
09/2012 - 09/2000
3Injections
01/2010 - 10/2000